Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | 0.0% | −5.0% | +0.9% | −6.0% | +4.5% | −6.1% | +1.8% | −36.2% | — | −12.1% |
| Peer average | −0.9% | −4.9% | −6.0% | −15.9% | −17.3% | −19.0% | +16.2% | −27.0% | +20.7% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$99 of every $1,000 in KURE is Beone
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 6160.HKBeone Medicines | Healthcare | 9.89% | $989.42 | 342K | $10.9M |
| 2 | 1801.HKInnovent Biologics | Healthcare | 8.15% | $814.56 | 837K | $9.0M |
| 3 | 2269.HKWuxi Biologics Cayman | Healthcare | 7.49% | $748.79 | 1.4M | $8.2M |
| 4 | 603259.SSWuxi Apptec | Healthcare | 5.58% | $557.91 | 283K | $6.1M |
| 5 | 300760.SZShenzhen Mindray Bio-medic | Healthcare | 4.65% | $465.47 | 185K | $5.1M |
| 6 | 600276.SSJiangsu Hengrui Pharmaceut | Healthcare | 4.62% | $462.42 | 705K | $5.1M |
| 7 | 1177.HKSino Biopharmaceutical | Healthcare | 4.03% | $402.70 | 6.3M | $4.4M |
| 8 | 1093.HKCspc Pharmaceutical Group LT | Healthcare | 3.42% | $341.71 | 3.6M | $3.8M |
| 9 | 2359.HKWuxi Apptec -H | Healthcare | 3.19% | $318.91 | 145K | $3.5M |
| 10 | 3692.HKHansoh Pharmaceutical Group | Healthcare | 3.15% | $315.36 | 802K | $3.5M |
| 11 | 9926.HKAkeso | Healthcare | 3.11% | $310.79 | 418K | $3.4M |
| 12 | 000538.SZYunnan Baiyao Group | Healthcare | 2.59% | $258.88 | 339K | $2.8M |
| 13 | 1548.HKGenscript Biotech | Healthcare | 2.55% | $254.56 | 720K | $2.8M |
| 14 | 688271.SSShanghai United Imaging He | Healthcare | 2.54% | $254.34 | 157K | $2.8M |
| 15 | 300015.SZAier EYE Hospital Group | Healthcare | 2.17% | $217.41 | 1.8M | $2.4M |
Every fund here earned less than cash (3.8%) over the past year; the bars still rank them by return for the bumps.
of the $18.7B in 24 China ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | 6160.HK | Beone Medicines | 9.89% |
| 2 | 1801.HK | Innovent Biologics | 8.15% |
| 3 | 2269.HK | Wuxi Biologics Cayman | 7.49% |
| 4 | 603259.SS | Wuxi Apptec -A | 5.58% |
| 5 | 300760.SZ | Shenzhen Mindray Bio-medic-a | 4.65% |
| 6 | 600276.SS | Jiangsu Hengrui Pharmaceut-a | 4.62% |
| 7 | 1177.HK | Sino Biopharmaceutical | 4.03% |
| 8 | 1093.HK | Cspc Pharmaceutical Group LT | 3.42% |
| 9 | 2359.HK | Wuxi Apptec -H | 3.19% |
| 10 | 3692.HK | Hansoh Pharmaceutical Group | 3.15% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 23, 2025 | $0.71 |
| Dec 17, 2024 | Dec 18, 2024 | $0.18 |
| Dec 18, 2023 | Dec 20, 2023 | $0.11 |
| Dec 28, 2022 | Dec 30, 2022 | $0.0104 |
| Dec 29, 2021 | Dec 31, 2021 | $4.05 |
| Dec 29, 2020 | Dec 31, 2020 | $0.0001 |
| Dec 27, 2019 | Dec 31, 2019 | $0.0573 |
| Dec 26, 2018 | Dec 28, 2018 | $0.0760 |